Vazyme
Manufacturing · China · 11-50 Employees
View Company Info for Free
Overview
Headquarters
ChinaPhone Number
+86 4006009335Website
www.vazymbiotech.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Vazyme
Founded in 2012, Nanjing Vazyme Biotech Co., Ltd is one of the few R&D-focused innovative biotechnology firms in China that has capabilities in developing upstream technologies in-house and manufacturing finished products. With an ongoing commitment to innovation and based on its proprietary key generic technology platform, the company has built a business network spanning biological research, in vitro diagnosis and biomedicine. Vazyme has developed eight series of proprietary POCT diagnostic reagents and related control materials covering cardiovascular and cerebrovascular diseases, inflammation, prepotency, gastric functions, autoimmunity, renal functions, chronic disease management as well as respiratory diseases.Explore more
Popular SearchesVazymeSIC Code 38,384NAICS Code 33,339Show moreVazyme Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vazyme your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check if Vazyme has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Vazyme recently announced quarterly report
Vazyme, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Vazyme launches new products
Congratulate Masked Content for being promoted to Masked Content at Vazyme
Check out if Vazyme is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Vazyme has new funding data
Click to see if Vazyme had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Vazyme
Find more new buyers
Company Profile Activity
Activity Insights
Vazyme is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Vazyme is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Vazyme.
Vazyme financials insights
Gather financial insights about Vazyme, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series C
$78M
Vazyme News & Media
Ready to Enter the Middle East Market, Vazyme Showcases Its COVID-19 Testing Solutions at Medlab Middle East 2022
DUBAI, UAE, Jan. 28, 2022 /PRNewswire/ -- Leading China-based biotech company Vazyme (688105.SH) participated in the 2022 edition of Medlab Middle East in the Dubai World Trade Centre (DWTC) from January 24th to 27th, a leading laboratory and flagship exhibition and conference that brings...Vazyme Attends Medica 2021 in Germany to Accelerate Its Global Market Expansion
DUSSELDORF, Germany, Nov. 19, 2021 /PRNewswire/ -- Chinese biotechnology company Vazyme (688105.SH) recently attended Medica 2021 in Germany—one of the world's largest events for the medical sector—to accelerate the expansion of its international business. At the event, Vazyme introduced...Vazyme goes public on Shanghai Stock Exchange today
NANJING, China, Nov. 15, 2021 /PRNewswire/ -- On November 15, 2021, Nanjing Vazyme Biotech Co., Ltd. (Vazyme) went public on the STAR MARKET of the Shanghai Stock Exchange under the stock code 688105. Founded in Nanjing in 2012, Vazyme develops technologies and products related to...Vazyme to Reveal Its Latest COVID-19 Testing Products and Solutions at MEDICA 2021
DÜSSELDORF, Germany, Nov. 3, 2021 /PRNewswire/ -- Chinese biotechnology company Nanjing Vazyme Biotech Co., Ltd (Vazyme) will exhibit its advanced COVID-19 testing products and solutions in Hall 3 Stand F 94 at MEDICA 2021, the world's leading trade fair for the medical sector, in Messe...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vazyme
Sign Up For FreeTo access detailed company insights
Founded in 2012, Nanjing Vazyme Biotech Co., Ltd is one of the few R&D-focused innovative biotechnology firms in China that has capabilities in developing upstream technologies in-house and manufacturing finished products. With an ongoing commitment to innovation and based on its proprietary key generic technology platform, the company has built a... Read More
